5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.15▼ | 4.14▼ | 4.13▼ | 4.26▼ | 3.73▲ |
MA10 | 4.16▼ | 4.13▼ | 4.13▼ | 4.09▲ | 4.55▼ |
MA20 | 4.15▼ | 4.14▼ | 4.19▼ | 3.80▲ | 5.25▼ |
MA50 | 4.15▼ | 4.26▼ | 4.15▼ | 4.71▼ | 4.41▼ |
MA100 | 4.21▼ | 4.11▼ | 3.85▲ | 5.21▼ | 3.67▲ |
MA200 | 4.21▼ | 3.81▲ | 3.92▲ | 4.67▼ | 3.05▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.008▼ | 0.005▲ | -0.017▼ | 0.121▲ | -0.292▼ |
RSI | 41.732▼ | 43.458▼ | 45.483▼ | 48.830▼ | 43.067▼ |
STOCH | 55.015 | 65.351 | 56.561 | 64.387 | 12.721▼ |
WILL %R | -85.185▼ | -60.526 | -70.000 | -46.685 | -75.058▼ |
CCI | -134.312▼ | -89.676 | -111.111▼ | 39.445 | -51.373 |
CDL | $DMAC Doji Candlestick Pattern Detected | Set Alert |
Friday, April 25, 2025 06:14 AM
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...
|
Tuesday, April 22, 2025 07:39 AM
Real time quote data is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.
|
Tuesday, April 15, 2025 06:38 PM
With a modest cash runway into Q3 2026, DMAC faces significant competition and limited near-term catalysts, making it a high-risk speculative hold. This is my first DiaMedica Therapeutics (NASDAQ ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 4.075 | 4.095 | 4.075 | 4.095 | 5,711 |
01/05/25 | 4.14 | 4.3445 | 4.005 | 4.13 | 64,205 |
30/04/25 | 4.28 | 4.4676 | 4.05 | 4.15 | 47,584 |
29/04/25 | 4.63 | 4.63 | 4.25 | 4.28 | 89,126 |
28/04/25 | 3.93 | 4.8082 | 3.90 | 4.64 | 240,436 |
25/04/25 | 4.13 | 4.23 | 3.861 | 4.04 | 56,299 |
24/04/25 | 3.98 | 4.195 | 3.98 | 4.17 | 89,322 |
23/04/25 | 3.985 | 4.0684 | 3.70 | 3.96 | 102,651 |
22/04/25 | 3.58 | 3.88 | 3.565 | 3.88 | 134,456 |
21/04/25 | 3.51 | 3.54 | 3.335 | 3.53 | 72,646 |
|
|
||||
|
|
||||
|
|